Arlington Capital Partners, a private investment firm specialising in government regulated industries, has made a majority investment in Afton Scientific, a US contract, development and manufacturing organisation dedicated to sterile manufacturing of injectable pharmaceuticals.

An affiliate of HIG Capital, a global alternative asset investment firm with $60bn of capital under management, has completed the take-private acquisition of DX Group, a British mail, courier and logistics company, for an aggregate consideration of £307m.

Union Square Advisors, a technology-focused investment bank, is expecting to see an increase in technology sector deal-making in 2024, with recent positive momentum continuing over the course of the year.

Trilantic Europe, a European private equity firm with a dedicated energy transition strategy, has acquired a 60% stake in AEROCOMPACT Group, a supplier of solar mounting solutions specialising in the development, production and distribution of substructures for mounting photovoltaic modules.

UK-based private equity firm Exponent is to acquire Galway-based generic drugmaker Channelle Pharma, in a deal said to be worth about €300m, after beating off competition from other PE firms, according to a report by the Irish Times.

Bridgepoint’s Bridgepoint Development Capital IV, a fund focused on investing in mid-market growth businesses, has made a strategic investment in next generation cloud and digital transformation services provider, Kerv Group.

New Heritage Capital, a Boston-based private equity firm focused on mid-market, founder-owned businesses, has exited its investment in Revela Foods, a developer and manufacturer of dairy-flavoured ingredients and solutions, to ADM, a global human and pet nutrition company.

TPG, a global alternative asset management firm with $212bn in assets, has made an investment in G&A Partners via its US and European private equity platform, TPG Capital, in partnership with the HR and technology services platform’s existing management team.